Primary sarcomas of the mediastinum are rare, and data concerning trea
tment and results of therapy are sparse, Objective: To assess presenta
tion, management, prognostic factors, and survival in mediastinal sarc
omas. Methods: We reviewed our experience,vith 47 patients with the di
agnosis of primary sarcoma of the mediastinum, Data were collected fro
m a computerized institutional database and medical records, Survival
was analyzed by Kaplan-Meier method and comparisons of survival by log
rank test. Results: The median age of 47 patients with mediastinal sa
rcoma was 39 years (range 2.5 to 69 years), with a male/female ratio o
f 1.6, The most common complaints were chest/shoulder pain (38%) and d
yspnea (23%), The most common tumor types were malignant peripheral ne
rve tumor (26%), spindle cell sarcoma (15%), leiomyosarcoma (9%), and
liposarcoma (9%). Operation was the primary treatment modality in 72%
of cases (n = 34); 22 sarcomas (47%) were completely resected, The ove
rall 5-year survival was 32%. High-grade lesions had a significantly d
ecreased survival (5-year survival = 27%) compared with low-grade tumo
rs (5-year survival = 66%) (p = 0.05), The overwhelming factor determi
ning survival was the ability to completely resect the tumors (5-year
survival 49% for complete resection; 3-year survival 18% for incomplet
e or no resection) (p = 0.0016), Despite complete resection, local rec
urrence occurred in 64% of cases, Conclusion: Because the overall surv
ival for patients with mediastinal sarcomas is 32% and the local recur
rence is 64% for tumors completely resected, aggressive adjuvant thera
py should continue to be systematically explored.